LipoNova AG: Local Supervisory Agency Approves Production license of LipoNova’s Early-Stage Kidney Cancer Vaccine Reniale®
***
LipoNova AG reaches key milestones in the Reniale development process during 2007. Costs below budget.
***
LipoNova signs memorandum of understanding for the marketing of Reniale®
***
Our Business
Vision / Strategy
Business Model
Company Profile
Partnering
-
Annual Shareholder Meeting 2008
Our Team
Management Team
Supervisory Board
International Advisory Board
Clinical Advisory Board Reniale
Product Development
Clinical Studies
Pipeline Status
Renal Cell Carcinoma
Therapeutic Focus
Investor Relations
Contact
Contact
Route Planner
Map
Careers
News/Press
Press Releases
Media Coverage
Publications
